Case Study: Phebra achieves GMP-compliant asset management with Mainpac EAM

One of Australia’s largest pharmaceutical groups Phebra chose Mainpac for its Asset Management requirements

Phebra, one of Australia’s largest privately-owned pharmaceutical groups, faced a challenge with its maintenance scheduling tool. The company required a more effective enterprise asset management solution that offered greater functionality and, critically, met the strict compliance requirements of 21 CFR Part 11 set by the FDA.

Mainpac provided a solution that met Goods Manufacturing Practice (GMP) requirements, offering the necessary security features, audit trails, and reporting capabilities. As a result, Phebra now uses Mainpac EAM to manage its operational assets and maintenance in a secure, compliant environment. The company cited Mainpac's competitive ongoing costs and local support as key deciding factors and plans to expand its use of the software for future needs.

Phebra